Equity Details
Price & Market Data
Price: $0.0₃2
Daily Change: $0.00 / 0.00%
Daily Range: $0.0₃2 - $0.0₃2
Market Cap: $3,100
Daily Volume: 150
Performance Metrics
1 Week: -87.50%
1 Month: %
3 Months: %
6 Months: -98.67%
1 Year: 19,900%
YTD: -99.01%
About Hemagen Diagnostics, Inc. (HMGN)
Understand the current valuation of Hemagen Diagnostics, Inc. (HMGN). Trading at 0.0₃2, the stock has observed a daily change of $0.00 / 0.00%. A robust market capitalization of 3,100 underscores its market presence. Key performance indicators include YTD (-99.01%) and 1-year (19,900%) returns.
Details
Hemagen Diagnostics, Inc. provides human and veterinary diagnostic services worldwide. The company develops, manufactures, and markets VIRGO, a human clinical diagnostic line of immunoassays for the diagnosis of autoimmune and infectious diseases, and acute phase proteins. Its proprietary test kits are used to aid in the diagnosis of certain autoimmune and infectious diseases. It also provides human diagnostics, such as universal IFA components; supplies, controls and calibrators, accessories, and H-rotors; reagents, electrodes, equipment; and specialty assays, including Chagas, acute phase proteins, and cytokines. In addition, the company offers veterinary diagnostic products, such as equipment, reagents, supplies, accessories, and electrodes in chemistry, hematology, and electrolyte areas. Its products are used in laboratories, hospitals and blood banks. Hemagen Diagnostics, Inc. was incorporated in 1985 and is based in Columbia, Maryland.